Q4 2024 Earnings Call Transcript March 24, 2025 OncoCyte Corporation misses on earnings expectations. Reported EPS is ...

A team that includes a RIKEN researcher has refined a lab test for measuring protein aggregate levels in samples from patients with certain neurodegenerative diseases. This has the potential to ...

The global therapeutic drug monitoring market is poised for significant expansion, with projections indicating a rise from USD 1,203.9 million in 2024 to an impressive USD 2,527.9 million by 2034.

Pharmaceutical company sponsorship of diagnostic testing remains an area with a gaping divide between the views of regulators and industry, ...

ON ASTRAZENECA ASSAY DEVELOPMENT PROJECTS AND SUCCESSFUL COMPLETION OF EISAI CONTRACT Development of both the prostate cancer ...

Taking steps towards eradicating tuberculosis (TB), the Government of India has launched the 100-Day TB Mukt Bharat Abhiyan ...

Increasing Accessibility for Flow Cytometry Applications in Emerging and Established Markets Cytek Muse Micro The Cytek® ...

A recently identified bacterial protein structure is contributing to the design of novel anticancer drug delivery systems.

BB-1701 has survived Eisai’s decision not to option the HER2-directed antibody-drug conjugate. | BB-1701 has survived Eisai’s ...

A fluorescent micrograph of a section of brain affected by Parkinson's disease. Neuron nuclei are blue, while the protein ...

Public health labs have handled most testing thus far for the Texas and New Mexico outbreaks, but commercial labs are beginning to bring molecular measles assays online.